Dr. Peter Czarnecki is the recipient of the Boston Marathon Chair of Research for $30,000.
PC: I am originally from Germany, and I graduated from Freiburg University Medical School in 2005. I did my residency in Internal Medicine and my fellowship in Critical Care Medicine at the Mayo Clinic in Rochester, MN, and I did my second fellowship in Nephrology at BIDMC in Boston.
PC: As a Nephrologist, I specialize in genetic diseases of the kidney, specifically Polycystic Kidney Disease. About 10-12% of patients with PKD have a brain aneurysm, and despite the focus on their kidney problems, the presence of a brain aneurysm may be the most serious complication of their disease.
PC: We want to test, if mutations in known kidney disease genes are found in brain aneurysm patients, even if they do not have known kidney problems
PC: If we determine that certain gene mutations cause brain aneurysms, then a simple gene test would result in a recommendation for MRI screening, and we could potentially identify many aneurysms before they cause problems
OA: This is an area of high unmet need. The clinical impact of detecting aneurysms in otherwise asymptomatic patients is high. Preliminary results coming out of our proposed study can then motivate bigger funding agencies like the NIH or AHA to support larger projects. Therefore, BAF support is a very important seed, and our research may serve as a multiplier.
Pictured above is Dr. Czarnecki’s research poster, “The Role of Polycystic Kidney Disease Gene Variants in Brain Aneurysm Development”
Our site uses cookies to personalize features and, via third-parties, to collect metrics on usage so that we can better tailor our site to the needs of our users. You can view our full cookie and privacy policies via the links below. To fully experience our site, please click Accept.